483 InvaGen Pharmaceuticals Mar 2013

483 InvaGen Pharmaceuticals Mar 2013

Robert Horan FDA$119.00 - Available Now

FDA investigators audited the InvaGen Pharmaceuticals - Hauppauge, NY, United States facility and issued 3 inspectional observations (via FDA 483) on 08 Mar 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 08 Mar 2013
  • Location: Hauppauge, United States
  • FEI: 3003950641
Add To Cart